Comparative study of the effect of LPS on the function of BALB/c and C57BL/6 peritoneal macrophages

Cell Journal

Volumn 15, Issue 1, 2013, Pages 45-54

  Soudi, Sara ^a   Zavaran Hosseini, Ahmad ^a   Hassan, Zuhair Muhammad ^a   Soleimani, Masoud ^a   Adegani, Fatemeh Jamshidi ^b   Hashemi, Seyed Mahmoud ^a,b  

^a TARBIAT MODARES UNIVERSITY   (Iran)

^b STEM CELL TECHNOLOGY RESEARCH CENTER   (Iran)

Author keywords

BALB c; C57BL 6; LPS; Macrophage; Thioglycolate

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; GAMMA INTERFERON; INDOLEAMINE 2,3 DIOXYGENASE; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 4; LIPOPOLYSACCHARIDE; NITRIC OXIDE; THIOGLYCOLIC ACID; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL EXPERIMENT; ARTICLE; CELL PROLIFERATION; COLORIMETRY; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; IMMUNE RESPONSE; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PHAGOCYTOSIS; SPLEEN CELL;

EID: 84877302125     PISSN: 22285806     EISSN: 22285814     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Lu YC, Yeh WC, Ohashi PS. LPS/TLR4 signal transduction pathway. Cytokine. 2008; 42(2): 145-151.
2. Schroder K, Sweet MJ, Hume DA. Signal integration between IFNgamma and TLR signalling pathways in macrophages. Immunobiology. 2006; 211(6-8): 511-524.
3. Rieger AM, Hall BE, Barreda DR. Macrophage activation differentially modulates particle binding, phagocytosis and downstream antimicrobial mechanisms. Dev Comp Immunol. 2010; 34(11): 1144-1159.
4. 2 paradigm. J Immunol. 2000; 164(12): 6166-6173.
5. Verreck FA, de Boer T, Langenberg DM, van der Zanden L, Ottenhoff TH. Phenotypic and functional profiling of human proinflammatory type-1 and anti-inflammatory type-2 macrophages in response to microbial antigens and IFNgamma- and CD40L-mediated costimulatio Phenotypic and functional profiling of human proinflammatory type-1 and anti-inflammatory type-2 macrophages in response to microbial antigens and IFN-gamma- and CD40L-mediated costimulation. J Leukoc Biol. 2006; 79(2): 285-293.
6. Wu CX, Sun H, Liu Q, Guo H, Gong JP. LPS induces HMGB1 relocation and release by activating the NF-κB-CBP signal transduction pathway in the murine macrophage-like cell line RAW264.7. J Surg Res. 2012; 175(1): 88-100.
7. Lee CJ, Tai YT, Lin YL, Chen RM. Molecular mechanisms of propofol-involved suppression of no biosynthesis and inducible iNOS gene expression in LPS-stimulated macrophage-like raw 264.7 cells. Shock. 2010; 33(1): 93-100.
8. Ekman AK, Fransson M, Rydberg C, Adner M, Cardell LO.Nasal challenge with LPS stimulates the release of macrophage inflammatory protein 1alpha. Int Arch Allergy Immunol. 2009; 149(2): 154-160.
9. Ghosn EE, Cassado AA, Govoni GR, Fukuhara T, Yang Y, Monack DM, et al. Two physically, functionally, and developmentally distinct peritoneal macrophage subsets. Proc-NatlAcadSci U S A. 2010; 107(6): 2568-2573.
10. Kleveta G, Borzecka K, Zdioruk M, Czerkies M, Kuberczyk H, Sybirna N, et al. LPS induces phosphorylation of actin-regulatory proteins leading to actin reassembly and macrophage motility. J Cell Biochem. 2012; 113(1): 80-92.
11. Kanaan Z, Gardner S, Carruba C, Mattingly J, Druen D, Cheadle WG. Macrophage genetic reprogramming during chronic peritonitis is augmented by LPS pretreatment. J Surg Res. 2011; 175(2): 289-297.
12. (Yakhteh). 2006; 8(2): 106-113.
13. Casals-Casas C, Alvarez E, Serra M, de la Torre C, Farrera C, Sánchez-Tilló E, et al. CREB and AP-1 activation regulates MKP-1 induction by LPS or M-CSF and their kinetics correlate with macrophage activation versus proliferation. Eur J Immunol. 2009; 39 (7): 1902-1913.
14. Puntambekar SS, Davis DS, Hawel L 3rd, Crane J, Byus CV, Carson MJ.LPS-induced CCL2 expression and macrophage influx into the murine central nervous system is polyamine-dependent. Brain Behav Immun. 2011; 25(4): 629-639.
15. Meng F, Lowell CA. Lipopolysaccharide (LPS)-induced macrophage activation and signal transduction in the absence of Src-family kinases Hck, Fgr, and Lyn. J Exp Med. 1997; 185(9): 1661-1670.
16. Monsalve E, Ruiz-García A, Baladrón V, Ruiz-Hidalgo MJ, Sánchez-Solana B, Rivero S, et al. Notch1 upregulates LPS-induced macrophage activation by increasing NFkappaB activity. Eur J Immunol. 2009; 39(9): 2556-2570.
17. Kollipara RK, Perumal NB. Motif prediction to distinguish LPS-stimulated pro-inflammatory vs. antibacterial macrophage genes. Immunome Res. 2010; 6: 5.
18. Fuentes AL, Millis L, Sigola LB. Laminarin, a soluble betaglucan, inhibits macrophage phagocytosis of zymosan but has no effect on lipopolysaccharide mediated augmentation of phagocytosis. Int Immunopharmacol. 2011; 11(11): 1939-1945.
19. Takahashi J, Sekine T, Nishishiro M, Arai A, Wakabayashi H, Kurihara T, et al.Inhibition of NO production in LPSstimulated mouse macrophage-like cells by trihaloacetylazulene derivatives. Anticancer Res. 2008; 28(1 A): 171-178.
20. Jung CH, Jung H, Shin YC, Park JH, Jun CY, Kim HM, et al.Eleutherococcussenticosus extract attenuates LPSinduced iNOS expression through the inhibition of Akt and JNK pathways in murine macrophage. J Ethnopharmacol. 2007; 113(1): 183-187.
21. Fock RA, Vinolo MA, de MouraSá Rocha V, de Sá Rocha LC, Borelli P. Protein-energy malnutrition decreases the expression of TLR-4/MD-2 and CD14 receptors in peritoneal macrophages and reduces the synthesis of TNFalpha in response to lipopolysaccharide (LPS) in mice. Cytokine. 2007; 40(2): 105-114.
22. Forte G, Sorrentino R, Montinaro A, Pinto A, Morello S. Cl-IB-MECA enhances TNF-α release in peritoneal macrophages stimulated with LPS. Cytokine. 2011; 54(2): 161-166.
23. Ding A, Nathan CF, Graycar J, Derynck R, Stuehr DJ, Srimal S. Macrophage deactivating factor and transforming growth factors-beta 1 -beta 2 and -beta 3 inhibit induction of macrophage nitrogen oxide synthesis by IFN-gamma. J Immunol. 1990; 145(3): 940-944.
24. Vodovotz Y, Bogdan C, Paik J, Xie QW, Nathan C. Mechanisms of suppression of macrophage nitric oxide release by transforming growth factor beta. J Exp Med. 1993; 178(2): 605-613.
25. Albina JE, Mills CD, Henry WL Jr, Caldwell MD. Temporal expression of different pathways of 1-arginine metabolism in healing wounds. J Immunol. 1990; 144(10): 3877-3880.
26. Mills CD, Shearer J, Evans R, Caldwell MD. Macrophage arginine metabolism and the inhibition or stimulation of cancer. J Immunol. 1992; 149(8): 2709-2714.
27. Munn DH, Shafizadeh E, Attwood JT, Bondarev I, Pashine A, Mellor AL. Inhibition of T cell proliferation by macrophage tryptophan catabolism. J Exp Med. 1999; 189(9): 1363-1372.
28. Munn DH, Armstrong E. Cytokine regulation of human monocyte differentiation in vitro: the tumor-cytotoxic phenotype induced by macrophage colony-stimulating factor is developmentally regulated by gamma-interferon. Cancer Res. 1993; 53(11): 2603-2613.
29. Marcil A, Harcus D, Thomas DY, Whiteway M.Candida albicans killing by RAW 264.7 mouse macrophage cells: effects of Candida genotype, infection ratios, and gamma interferon treatment. Infect Immun. 2002; 70(11): 6319-6329.